Close Menu
    What's Hot

    Credit Commercial de France Pension Scheme Completes Bulk Purchase Annuity Buy-In With Royal London

    July 23, 2026

    Smiths Industries Pension Scheme Completes Bulk Purchase Annuity Buy-In With M&G

    July 23, 2026

    End-Game Clarity Shaping UK Pension Risk Transfer Market but Large Schemes Still on the Sidelines

    July 22, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Big Year of Growth for Life/Annuity Sidecar-Like Activity in 2025

      July 2, 2026

      Sixth Street To Become Majority Shareholder of Monument Re

      June 30, 2026

      Pacific Life Re Appoints Florence Durousseau as Head of Capital Solutions, Europe

      June 15, 2026

      Third Block Reinsurance Deal With Tokio Marine & Nichido Life for Pacific Life Re

      June 10, 2026

      Shaping the Future of Health Insurance Through Innovation and Analytics

      June 10, 2026

      Q&A: Dr Christoph Schmitt, Director, Insurance, Fitch Ratings

      May 28, 2026

      Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

      May 13, 2026

      US Annuity Sales Notch Tenth Consecutive $100bn+ Quarter

      May 11, 2026

      Credit Commercial de France Pension Scheme Completes Bulk Purchase Annuity Buy-In With Royal London

      July 23, 2026

      Smiths Industries Pension Scheme Completes Bulk Purchase Annuity Buy-In With M&G

      July 23, 2026

      End-Game Clarity Shaping UK Pension Risk Transfer Market but Large Schemes Still on the Sidelines

      July 22, 2026

      Q&A: Yona Chesner, Head of Pensions Investment, Cartwright Pension Trusts

      July 22, 2026

      Record Low Mortality Rates So Far in England and Wales in 2026

      July 9, 2026

      Organ Transplant Improvements Test Life Expectancy Assessment Models

      July 8, 2026

      The Pursuit of Everlasting Life Unlikely to Shift Actuarial Models

      June 10, 2026

      Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

      April 9, 2026
      Litigation

      Litigation Update: Estate of Martha Barotz v. Wilmington Savings Fund Society, FSB, et al.

      July 22, 2026

      South Dakota Supreme Court Upholds Life Settlement Investor’s Right to Retain $10 Million Death Benefit

      July 22, 2026

      Optimism for Stronger Second Half in the Life Settlement Tertiary Market

      July 8, 2026

      US Life Insurers Embrace Securitised Credit as Demand for Yield and Diversification Grows but Hurdles Remain for Longevity-Linked Assets

      July 8, 2026

      Credit Commercial de France Pension Scheme Completes Bulk Purchase Annuity Buy-In With Royal London

      July 23, 2026

      Smiths Industries Pension Scheme Completes Bulk Purchase Annuity Buy-In With M&G

      July 23, 2026

      End-Game Clarity Shaping UK Pension Risk Transfer Market but Large Schemes Still on the Sidelines

      July 22, 2026
      Litigation

      Litigation Update: Estate of Martha Barotz v. Wilmington Savings Fund Society, FSB, et al.

      July 22, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 7, July 2026

      July 8, 2026

      Editor’s Letter – Volume 2, Issue 6, June 2026

      June 10, 2026

      Editor’s Letter – Volume 2, Issue 5, May 2026

      May 13, 2026

      Editor’s Letter – Volume 2, Issue 4, April 2026

      April 9, 2026

      Editor’s Letter – Volume 2, Issue 3, March 2026

      March 11, 2026
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    Will the US Asset Intensive Life Reinsurance Market Continue Recent Growth Spurt?

    Life Insurance Capital Solutions April 22, 2026By Greg Winterton
    Share
    Twitter LinkedIn Email

    The asset intensive life reinsurance (AILR) market in the US got its start in the aftermath of the Global Financial Crisis; the reduction in interest rates and regulatory changes made fixed deferred annuity books less palatable to hold on life insurance company balance sheets, with reinsurers offering a more fitting home for these liabilities. 

    But in the past almost 20 years, the global AILR market has now grown to an all-time high of approximately $160bn in 2025, according to new data published by broker, Guy Carpenter. 

    The aggregate value has risen in each of the last four years, a recovery since a steep drop-off from 2021 to 2022. But what’s more notable about the data is that third-party capital – essentially, alternative asset manager-owned reinsurers – now accounts for approximately one-third of the total, more than double the levels from 2022. 

    US capital markets investors in particular are keen to tap into the ‘permanent capital’ that the life and annuity market provides, and these structures are enabling them to direct this capital into private assets they originate themselves or access via partnerships with other asset management firms. 

    But they, and the traditional reinsurers, are working in a different environment now than the one that began around 2008-09. 

    “There are a couple of components that are new-ish in the market. First is the tremendous volume of new capital coming into a market where there are finite liabilities to reinsure. That creates a demand and supply conundrum that influences pricing dynamics,” said Richard de Haan, Global Risk Modelling Services Leader at PwC in New York. 

    “Also, in the last three to four years, we’ve started to see more complex liabilities being traded in the US marketplace – products such as universal life with secondary guarantees where you have more policyholder behaviour risk, variable annuity transactions which bring market risk and demographic risk and long-term care related transactions which involve longevity risk. The complexity of the underlying liabilities has changed significantly. More complex liabilities require greater due diligence and understanding of the risks associated with that,” he added. 

    One would assume that this added complexity would be something of a speed bump on the road to growth but that doesn’t seem to be the case here. And neither is the new actuarial guideline AG 55, which has been designed to provide regulators with more transparency into the asset adequacy of offshore AILR structures, which in turn forces a fundamental shift in how cedants report risk. 

    One of the features of AG 55 is the new attribution analysis, a mandatory disclosure designed to bridge the gap between US statutory reserves and offshore levels. It provides a step-by-step breakdown of reserve decreases that attributes changes to specific factors like discount rates, mortality assumptions, and policyholder behaviour to ensure transparency in cross-border capital relief. 

    The initial filing deadline was at the beginning of April, and whilst it might be too early to tell what kind of impact this new requirement might have on the US market generally, activity in the space hasn’t been notably affected yet. 

    “This first round of AG55 is really information gathering. As counterparties provide information, like anything, the regulators look and assess – “Is there something we weren’t aware of and do we have to do something?” It’s hard to tell right now exactly what will change, but it hasn’t dampened any transactions to date and clients we speak to view it as good governance, something that is just the normal course of business,” said De Haan. 

    In the UK pension risk transfer market, there has emerged something of a systematising of transactions in the smaller end of the market. Both life insurers and brokers now have something of an ‘off-the-shelf’ solution that is helping get more deals over the line. 

    That’s not something that is likely to happen in the AILR space, however. The transactions are not only complex, but the market doesn’t really have a ‘smaller end’ in the same way that the PRT space does. 

    Add to that the fact that regulators are already involved in many stages of the transaction, and it becomes clear that the 9–12-month timeframe that this market frequently sees is not changing any time soon. 

    “There are just so many different permutations of these structures – they’re influenced by the underlying block of business, the jurisdiction and the relationship between different counterparties. It’s not one cedant to one reinsurer – often, three or four counterparties are involved. And then you have to seek approval from various regulators – the reality is that getting approvals from the board and management, and the regulators, particularly if they involve offshore structures, takes time,” said De Haan. 

    In a market that is complicated, where transactions take time, and where participants need to be large enough to absorb, then, what is the potential for growth to be as strong as it has been in recent years? After all, most of the large alternative investment firms in the US already participate in some way, shape or form and there is a finite amount of business that can be ceded. 

    That doesn’t mean that others might not have their eyes on trying to take a slice of the pie. But for any potential new entrants who might see a rising tide, there are two hurdles that are likely to be difficult to overcome for their boat. 

    “Sometimes it does seem like everyone wants to find a permanent capital source. But one of the biggest challenges for folks in the marketplace is finding skilled people who understand the insurance market and the ecosystem, and the nuances of structured vehicles involved in insurance,” said De Haan. 

    “Regulations, proper risk management, accounting, etc all cost money. If you don’t have scale, it’s very hard to be in this business and generate a decent enough return to stay in it. We’re already starting to see activity around consolidation in the US where M&A is being driven by the need to compete and the recognition that scale has to be at the heart of the strategy. And protecting the policy holder is the primary governance gate – a cedant is not going to choose the counterparty that simply gives the best price because the risk ultimately still sits with the cedant. New entrants would need other levers than just price to compete. That’s difficult.”  

    2026 - April Alternative Credit Alternative Risk Transfer Longevity Risk Volume 2 Issue 5 – May 2026
    Share. Twitter LinkedIn Email

    Related Posts

    Credit Commercial de France Pension Scheme Completes Bulk Purchase Annuity Buy-In With Royal London

    July 23, 2026By LMI Newsdesk

    Smiths Industries Pension Scheme Completes Bulk Purchase Annuity Buy-In With M&G

    July 23, 2026By LMI Newsdesk

    End-Game Clarity Shaping UK Pension Risk Transfer Market but Large Schemes Still on the Sidelines

    July 22, 2026By Mark McCord
    Litigation

    Litigation Update: Estate of Martha Barotz v. Wilmington Savings Fund Society, FSB, et al.

    July 22, 2026By Greg Winterton
    Latest Issue

    Optimism for Stronger Second Half in the Life Settlement Tertiary Market

    July 8, 2026

    Organ Transplant Improvements Test Life Expectancy Assessment Models

    July 8, 2026

    US Life Insurers Embrace Securitised Credit as Demand for Yield and Diversification Grows but Hurdles Remain for Longevity-Linked Assets

    July 8, 2026

    Passage of UK Pension Schemes Act Seen Boosting Size of DB Superfund Market

    June 24, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.